title: Acute generalized exanthematous pustulosis associated with 2 common medications: hydroxyzine and benzocaine.
authors.affiliation: University of Ottawa, Division of Dermatology, Canada.
authors.forename: Ashley
authors.initials: A
authors.lastname: O'Toole
authors.affiliation: University of Ottawa, Division of Dermatology, Canada.
authors.forename: Julie
authors.initials: J
authors.lastname: Lacroix
authors.affiliation: University of Ottawa, Division of Dermatology, Canada. Electronic address: prattderm@gmail.com.
authors.forename: Melanie
authors.initials: M
authors.lastname: Pratt
authors.affiliation: University of Ottawa, Division of Dermatology, Canada.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Beecker
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D000284:Administration, Oral; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D001566:Benzocaine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006919:Hydroxyzine / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D011241:Prednisone / Q000627:therapeutic use; D018570:Risk Assessment; D012494:Sampling Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D006919:Hydroxyzine; D001566:Benzocaine; D011241:Prednisone